https://doi.org/10.4081/monaldi.2021.1708
COVID-19: the difference between the nose and the lung
Published: March 5, 2021
Abstract Views: 1145
PDF: 565
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
An elegant study reported dysmorphic cells and syncytia in the deceased's lungs for COVID-19. The authors reasonably considered that most of these syncytia-forming cells were pneumocytes, as identified by specific biomarkers. However, cellular dysmorphism and syncytia are pathological features common in other respiratory infections caused by different viruses, including the human respiratory syncytial virus (HRSV) and Epstein-Barr virus (EBV), as correctly documented...
Bussani R, Schneider E, Zentilin L, et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 2020;61:103104.
DOI: https://doi.org/10.1016/j.ebiom.2020.103104
Gagliardi TB, Ferreira Criado M, Proenca-Modena JL, et al. Syncytia induction by clinical isolates of human respiratory syncytial virus A. Intervirology 2017;60:56-60.
DOI: https://doi.org/10.1159/000480014
Gelardi M, Tomaiuolo M, Cassano M, et al. Epstein-Barr virus induced cellular changes in nasal mucosa. Virology J 2006;3:6.
DOI: https://doi.org/10.1186/1743-422X-3-6
Gelardi M, Ciprandi G. Ciliocytophthoria of nasal epithelial cells after viral infection: a sign of suffering cell. Acta Biomed 2019;90:7-9.
Gelardi M, Notargiacomo M, Trecca EMC, Cassano M. SARS-CoV-2: Naso-bronchial cytological correlations. Am J Otolaryngol 2020;41:102549.
DOI: https://doi.org/10.1016/j.amjoto.2020.102549
How to Cite
Gelardi, Matteo, Mario Notargiacomo, Eleonora Maria Consiglia Trecca, Michele Cassano, and Giorgio Ciprandi. 2021. “COVID-19: The Difference Between the Nose and the Lung”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1708.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Mario Pacileo, Francesco Giallauria, Cristina Savarese, Teresa Cirillo, Fabio Crescibene, Anna Di Lorenzo, Mariacarla Ferrillo, Maria Grazia Calabrese, Carlo Vigorito, Antonello D'Andrea, The role of echocardiography in SARS-CoV-2 pandemic: a compromise among appropriateness, safety and clinical impact , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Sabah Ahmed Hussein, Hari Kishan Gonuguntla, Sarabon Tahura, Belgundi Preeti, Vishnu G Krishnan, Nitesh Gupta, Ahmed Al-Halfawy, Felix J Herth, Flexible bronchoscopy-assisted removal of aspirated scarf pins from the tracheobronchial tree: the experience of 146 subjects , Monaldi Archives for Chest Disease: Early Access
- Yash Kedia, Manu Madan, Rajnish Kaushik, Rohit Kumar, AJ Mahendran, Pranav Ish, Neeraj Gupta, Tanmaya Talukdar, Nitesh Gupta, Thoracoscopic blood patch instillation for persistent air leak in pneumothorax: a case series and systematic review , Monaldi Archives for Chest Disease: Early Access
- Shyam Kanhaiya Saroj, Tushti Bhardwaj, Non-pharmacological interventions for tobacco cessation: A systematic review of existing practices and their effectiveness , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Andrea Segreti, Sara Mastroberardino, Lorenzo Frau, Alessandro Appetecchia, Luca D’Antonio, Danilo Ricciardi, Gian Paolo Ussia, Francesco Grigioni, Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments , Monaldi Archives for Chest Disease: Early Access
- Komal Singh, Harshit Kadnur, Animesh Ray, Puneet Khanna, Akhil Singh, Naveet Wig, Anjan Trikha, Platypnea-orthodeoxia in a patient with severe COVID-19 pneumonia , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Amos Lal, Ajay Kumar Mishra, Jamal Akhtar, Christoph Nabzdyk, Pneumothorax and pneumomediastinum in COVID-19 acute respiratory distress syndrome , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Parul Mrigpuri, Sonal Sonal, Sonam Spalgais, Nitin Goel, Balakrishnan Menon, Raj Kumar, Uncontrolled diabetes mellitus: A risk factor for post COVID fibrosis , Monaldi Archives for Chest Disease: Vol. 91 No. 1 (2021)
- Martina Maria Seminara, Dina Visca, Alice Claudia Repossi, Antonio Spanevello, Mycobacterium chimaera: a case report from Italy , Monaldi Archives for Chest Disease: Early Access
- Matilde Boccia, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D'Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, Fabio Perrotta, COVID-19 and coagulative axis: review of emerging aspects in a novel disease , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
You may also start an advanced similarity search for this article.
